KFSH&RC TAPS DR. BJÖRN ZOÉGA TO FAST-TRACK GOAL AS LEADING HEALTHCARE INSTITUTION GLOBALLY

KUALA LUMPUR, April 3 (Bernama) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) has appointed Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective April 1.

According to a statement, this strategic move is set to accelerate KFSH&RC's aspiration of becoming a leading healthcare institution on the global stage, leveraging Dr. Zoéga's notable career and proven track record of leadership in top-tier medical institutions.

As Deputy CEO, he will serve as chief lead of KFSH&RC’s healthcare delivery and research and innovation groups, following on the hospital’s commitment to integrating global best practices in healthcare and pursuing cutting-edge medical research and technology.

Dr. Zoéga brings decades of healthcare management and clinical expertise to KFSH&RC, having spearheaded operations as CEO of the National University Hospital of Iceland and the Stockholm Spine Center.

As the former CEO of the internationally renowned Karolinska University Hospital in Sweden, he played a pivotal role in upholding the institution’s high standards and global recognition as the second highest rated among European hospitals and seventh best worldwide, according to Newsweek’s ranking of the World’s Best Hospitals 2024.

Dr. Zoéga’s administration at Karolinska was marked by innovative strategies and excellence in healthcare delivery—all which he posed to enrich within KFSH&RC.

His experience and faculties in research and education are also invaluable, given his former roles as President and Board Chairman of the EU-Cervical Spine Research Society and Chairman of the Scientific Advisory Board of Alvotech.

-- BERNAMA